LeMaitre Vascular LMAT reported its Q3 earnings results on Thursday, October 28, 2021 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
LeMaitre Vascular missed their estimated earnings by 6.25%, reporting an EPS of $0.3 versus an estimate of $0.32, which did not surprise analysts.
Revenue was up $1,952,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09, which was followed by a 0.24% drop in the share price the next day.
Here's a look at LeMaitre Vascular's past performance:
Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
---|---|---|---|---|
EPS Estimate | 0.31 | 0.27 | 0.29 | 0.19 |
EPS Actual | 0.40 | 0.28 | 0.34 | 0.37 |
Revenue Estimate | 37.97M | 35.20M | 35.58M | 31.62M |
Revenue Actual | 40.67M | 35.88M | 37.55M | 36.42M |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Guidance
LeMaitre Vascular management provided guidance for their next quarter, expecting earnings between $0.3 and $0.35 per share for the nextquarter.
This represents a 8.33% in quarter-over-quarter growth for LeMaitre Vascular, a bullish signal to many investors.
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.